49 results on '"Salenius, Sharon A"'
Search Results
2. Information Needs Expressed During Patient-Oriented Oncology Consultations: Quantity, Variation, and Barriers
3. Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk
4. Combining Immunotherapy and Radiation for Prostate Cancer
5. A Markov Chain Monte Carlo (MCMC) Multivariate Analysis of the Association of Vital Parameter Variation With the Lunar Cycle in Patients Hospitalized With COVID-19
6. Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer
7. Routine bladder cancer treatment dictates divergence from trial-derived regimens: Results of treatment at 44 radiotherapy centers
8. Diabetes Mellitus, Race and the Odds of High Grade Prostate Cancer in Men Treated With Radiation Therapy
9. Coronary Artery Revascularization and the Risk of Death in Men With Prostate Cancer
10. The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statement
11. A Survey of Clinical Research Coordinators in the Cooperative Group Setting of the American College of Radiology Imaging Network (ACRIN)
12. The Research Associate Committee of the ACR Imaging Network
13. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer
14. Coronary Artery Revascularization and the Risk of Death in Men With Prostate Cancer
15. Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation
16. Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke
17. Prostate Cancer-Specific Mortality and the Extent of Therapy in Healthy Elderly Men With High-Risk Prostate Cancer
18. Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy
19. Information Needs Expressed During Patient-Oriented Oncology Consultations: Quantity, Variation, and Barriers
20. Patients treated with bladder preserving trimodality chemoradiation therapy (BPTMCRT) off-trial compared to those on trials.
21. What do patients really want to know?
22. Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer–Specific Mortality Stratified by the Extent of Competing Mortality
23. Multi-center assessment of stereotactic body radiotherapy in oligometastatic prostate cancer.
24. Abstract 3438: Whole pelvis versus prostate-only radiotherapy with or without short course androgen deprivation therapy and mortality risk
25. Changes in prostate cancer presentation for radiation oncology care after USPSTF recommendations, 2007-2013.
26. Clinical outcomes of IMRT versus 3D-CRT in preoperative chemoradiotherapy for locally advanced rectal cancer (LARC) treated in a community setting.
27. Neoadjuvant Hormonal Therapy Use and the Risk of Death in Men with Prostate Cancer Treated with Brachytherapy Who Have No or at Least a Single Risk Factor for Coronary Artery Disease
28. Stability of white blood cell counts following standard radiation approaches for high-risk adenocarcinoma of the prostate: Implications for combination therapy.
29. The Number of High-Risk Factors and the Risk of Prostate Cancer–Specific Mortality After Brachytherapy: Implications for Treatment Selection
30. Type of Diabetes Mellitus and the Odds of Gleason Score 8 to 10 Prostate Cancer
31. Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men With High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction
32. Race and Survival Following Brachytherapy-Based Treatment for Men With Localized or Locally Advanced Adenocarcinoma of the Prostate
33. Risk of All-Cause and Prostate Cancer–Specific Mortality After Brachytherapy in Men With Small Prostate Size
34. Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation
35. Predictors of Prostate Cancer–Specific Mortality in Elderly Men With Intermediate-Risk Prostate Cancer Treated With Brachytherapy With or Without External Beam Radiation Therapy
36. Total Androgen Blockade Versus a Luteinizing Hormone–Releasing Hormone Agonist Alone in Men With High-Risk Prostate Cancer Treated With Radiotherapy
37. Risk of Death From Prostate Cancer After Brachytherapy Alone or With Radiation, Androgen Suppression Therapy, or Both in Men With High-Risk Disease
38. THE RISK OF PROSTATE CANCER DEATH FOR ELDERLY MEN WITH TREATED HIGH-RISK PROSTATE CANCER AND NO OR CORRECTED CARDIOVASCULAR DISEASE
39. Mandibular Metastasis in a Patient with Endometrial Cancer
40. Small-Cell Lung Carcinoma
41. Results of radiation therapy to the prostate in 25 patients with hormone-refractory disease
42. Small Cell Anaplastic Carcinoma of the Prostate: Seven New Cases, Review of the Literature, and Discussion of a Therapeutic Strategy
43. Medically inoperable lung carcinoma: The role of radiation therapy
44. Low doses of prophylactic cranial irradiation effective in limited stage small cell carcinoma of the lung
45. 1064 An integrated system for pre and post implant analysis for ultrasound guided prostate implantation
46. Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication
47. Radiation therapy in the management of medically inoperable carcinoma of the lungs: Results and implications for future treatment strategies
48. (P032) Stereotactic Body Radiation Therapy for Bone Metastases From Prostate Cancer: Techniques and Outcomes From a Large Community Setting.
49. (P032) Current Management of Low-Grade Central Nervous System Glioma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.